|
nasdaq:amrn
|
139711
|
Apr 21st, 2024 12:00AM
|
Amarin Corporation
|
30K
|
458.00
|
Open
|
|
Apr 20th, 2024 10:52PM
|
Apr 20th, 2024 10:52PM
|
Amarin is an innovative pharmaceutical company leading a new paradigm in cardiovascular disease management. We are committed to increasing the scientific understanding of the cardiovascular risk that persists beyond traditional therapies and advancing the treatment of that risk for patients worldwide. Amarin has offices in Bridgewater, New Jersey in the United States, Dublin in Ireland, Zug in Switzerland, and other countries in Europe as well as commercial partners and suppliers around the world.
For more information, visit www.amarincorp.com.
See our Community Guidelines: bit.ly/2L7xEW6
|
Open
|
Cardiovascular
|
Open
|
|
|
|
US
|
|
|
Amarin
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:amrn
|
139711
|
Apr 20th, 2024 12:00AM
|
Amarin Corporation
|
30K
|
458.00
|
Open
|
|
Apr 19th, 2024 10:43PM
|
Apr 20th, 2024 04:32PM
|
Amarin is an innovative pharmaceutical company leading a new paradigm in cardiovascular disease management. We are committed to increasing the scientific understanding of the cardiovascular risk that persists beyond traditional therapies and advancing the treatment of that risk for patients worldwide. Amarin has offices in Bridgewater, New Jersey in the United States, Dublin in Ireland, Zug in Switzerland, and other countries in Europe as well as commercial partners and suppliers around the world.
For more information, visit www.amarincorp.com.
See our Community Guidelines: bit.ly/2L7xEW6
|
Open
|
Cardiovascular
|
Open
|
|
|
|
US
|
|
|
Amarin
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:amrn
|
139711
|
Apr 19th, 2024 12:00AM
|
Amarin Corporation
|
30K
|
458.00
|
Open
|
|
Apr 18th, 2024 10:50PM
|
Apr 18th, 2024 10:50PM
|
Amarin is an innovative pharmaceutical company leading a new paradigm in cardiovascular disease management. We are committed to increasing the scientific understanding of the cardiovascular risk that persists beyond traditional therapies and advancing the treatment of that risk for patients worldwide. Amarin has offices in Bridgewater, New Jersey in the United States, Dublin in Ireland, Zug in Switzerland, and other countries in Europe as well as commercial partners and suppliers around the world.
For more information, visit www.amarincorp.com.
See our Community Guidelines: bit.ly/2L7xEW6
|
Open
|
Cardiovascular
|
Open
|
|
|
|
US
|
|
|
Amarin
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:amrn
|
139711
|
Apr 18th, 2024 12:00AM
|
Amarin Corporation
|
30K
|
458.00
|
Open
|
|
Apr 17th, 2024 10:54PM
|
Apr 18th, 2024 05:52PM
|
Amarin is an innovative pharmaceutical company leading a new paradigm in cardiovascular disease management. We are committed to increasing the scientific understanding of the cardiovascular risk that persists beyond traditional therapies and advancing the treatment of that risk for patients worldwide. Amarin has offices in Bridgewater, New Jersey in the United States, Dublin in Ireland, Zug in Switzerland, and other countries in Europe as well as commercial partners and suppliers around the world.
For more information, visit www.amarincorp.com.
See our Community Guidelines: bit.ly/2L7xEW6
|
Open
|
Cardiovascular
|
Open
|
|
|
|
US
|
|
|
Amarin
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:amrn
|
139711
|
Apr 17th, 2024 12:00AM
|
Amarin Corporation
|
30K
|
459.00
|
Open
|
|
Apr 16th, 2024 10:38PM
|
Apr 17th, 2024 02:16PM
|
Amarin is an innovative pharmaceutical company leading a new paradigm in cardiovascular disease management. We are committed to increasing the scientific understanding of the cardiovascular risk that persists beyond traditional therapies and advancing the treatment of that risk for patients worldwide. Amarin has offices in Bridgewater, New Jersey in the United States, Dublin in Ireland, Zug in Switzerland, and other countries in Europe as well as commercial partners and suppliers around the world.
For more information, visit www.amarincorp.com.
See our Community Guidelines: bit.ly/2L7xEW6
|
Open
|
Cardiovascular
|
Open
|
|
|
|
US
|
|
|
Amarin
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:amrn
|
139711
|
Apr 16th, 2024 12:00AM
|
Amarin Corporation
|
30K
|
459.00
|
Open
|
|
Apr 15th, 2024 10:38PM
|
Apr 16th, 2024 10:32AM
|
Amarin is an innovative pharmaceutical company leading a new paradigm in cardiovascular disease management. We are committed to increasing the scientific understanding of the cardiovascular risk that persists beyond traditional therapies and advancing the treatment of that risk for patients worldwide. Amarin has offices in Bridgewater, New Jersey in the United States, Dublin in Ireland, Zug in Switzerland, and other countries in Europe as well as commercial partners and suppliers around the world.
For more information, visit www.amarincorp.com.
See our Community Guidelines: bit.ly/2L7xEW6
|
Open
|
Cardiovascular
|
Open
|
|
|
|
US
|
|
|
Amarin
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:amrn
|
139711
|
Apr 15th, 2024 12:00AM
|
Amarin Corporation
|
30K
|
459.00
|
Open
|
|
Apr 14th, 2024 10:39PM
|
Apr 15th, 2024 04:13PM
|
Amarin is an innovative pharmaceutical company leading a new paradigm in cardiovascular disease management. We are committed to increasing the scientific understanding of the cardiovascular risk that persists beyond traditional therapies and advancing the treatment of that risk for patients worldwide. Amarin has offices in Bridgewater, New Jersey in the United States, Dublin in Ireland, Zug in Switzerland, and other countries in Europe as well as commercial partners and suppliers around the world.
For more information, visit www.amarincorp.com.
See our Community Guidelines: bit.ly/2L7xEW6
|
Open
|
Cardiovascular
|
Open
|
|
|
|
US
|
|
|
Amarin
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:amrn
|
139711
|
Apr 14th, 2024 12:00AM
|
Amarin Corporation
|
30K
|
460.00
|
Open
|
|
Apr 13th, 2024 10:34PM
|
Apr 14th, 2024 10:32AM
|
Amarin is an innovative pharmaceutical company leading a new paradigm in cardiovascular disease management. We are committed to increasing the scientific understanding of the cardiovascular risk that persists beyond traditional therapies and advancing the treatment of that risk for patients worldwide. Amarin has offices in Bridgewater, New Jersey in the United States, Dublin in Ireland, Zug in Switzerland, and other countries in Europe as well as commercial partners and suppliers around the world.
For more information, visit www.amarincorp.com.
See our Community Guidelines: bit.ly/2L7xEW6
|
Open
|
Cardiovascular
|
Open
|
|
|
|
US
|
|
|
Amarin
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:amrn
|
139711
|
Apr 13th, 2024 12:00AM
|
Amarin Corporation
|
30K
|
460.00
|
Open
|
|
Apr 12th, 2024 10:24PM
|
Apr 13th, 2024 11:00AM
|
Amarin is an innovative pharmaceutical company leading a new paradigm in cardiovascular disease management. We are committed to increasing the scientific understanding of the cardiovascular risk that persists beyond traditional therapies and advancing the treatment of that risk for patients worldwide. Amarin has offices in Bridgewater, New Jersey in the United States, Dublin in Ireland, Zug in Switzerland, and other countries in Europe as well as commercial partners and suppliers around the world.
For more information, visit www.amarincorp.com.
See our Community Guidelines: bit.ly/2L7xEW6
|
Open
|
Cardiovascular
|
Open
|
|
|
|
US
|
|
|
Amarin
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:amrn
|
139711
|
Apr 12th, 2024 12:00AM
|
Amarin Corporation
|
30K
|
460.00
|
Open
|
|
Apr 11th, 2024 10:27PM
|
Apr 12th, 2024 07:55AM
|
Amarin is an innovative pharmaceutical company leading a new paradigm in cardiovascular disease management. We are committed to increasing the scientific understanding of the cardiovascular risk that persists beyond traditional therapies and advancing the treatment of that risk for patients worldwide. Amarin has offices in Bridgewater, New Jersey in the United States, Dublin in Ireland, Zug in Switzerland, and other countries in Europe as well as commercial partners and suppliers around the world.
For more information, visit www.amarincorp.com.
See our Community Guidelines: bit.ly/2L7xEW6
|
Open
|
Cardiovascular
|
Open
|
|
|
|
US
|
|
|
Amarin
|
Health Care
|
Pharmaceuticals & Biotechnology
|